Anuh Pharma receives ₹9.93 lakh tax demand order for AY 2018-19
- Anuh Pharma received a ₹9.93 lakh tax demand for AY 2018-19
- The order cites disallowance of deductions claimed under the Income Tax Act
- Company plans to appeal before the Commissioner of Income Tax
- Management states no impact on financial operations or activities
*this image is generated using AI for illustrative purposes only.
Anuh Pharma received a demand order of ₹9.93 lakh from the Income Tax Department on September 18, 2026. The notice pertains to the assessment year 2018-19 and cites disallowances of certain deductions claimed under the Income Tax Act, 1961.
The order was issued by the Assessment Unit under Section 156 of the Income Tax Act. The company disclosed the development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Disclosure Details
| Particulars | Details |
|---|---|
| Authority | Income Tax Department, Assessment Unit |
| Nature of Order | Demand Order under Section 156 |
| Assessment Year | 2018-19 |
| Amount | ₹9,93,206 |
| Reason | Disallowance of deductions claimed |
| Date Received | September 18, 2026 |
Anuh Pharma stated it is filing an appeal before the Commissioner of Income Tax within prescribed timelines. Management believes it has adequate factual and legal grounds to substantiate its position.
Operational Impact
The company asserted that the tax demand has no impact on its financial operations or other activities. No provision was mentioned in the disclosure regarding the potential liability.
What the Numbers Show
The demand amount of ₹9.93 lakh is relatively modest for a listed pharmaceutical entity. The specific reference to "disallowances of deductions" suggests a dispute over expense eligibility rather than a fundamental reassessment of taxable income base. The company's decision to appeal immediately indicates confidence in its documentation, avoiding potential interest accruals associated with delayed payments.
Historical Stock Returns for Anuh Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.21% | +2.49% | +23.45% | +23.59% | +7.07% | -16.11% |
How might the outcome of this appeal influence Anuh Pharma's future tax compliance strategies and internal audit rigor?
Could this dispute signal a broader tightening of tax scrutiny on deduction claims within the Indian pharmaceutical sector?
What is the historical success rate of Anuh Pharma in resolving similar regulatory disputes, and how does it compare to industry peers?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
